Contact us  Chinese
Shanghai Newsummit Biopharma Co.Ltd
business solutions
core business

Core Business Model

Key Products

core competitive advantages

Core Competitive Advantages
& Industry Status

Newsummit CRO Service Network


China Torch Program-PCRD platform passed the acceptance test

On September 5th, 2014, commissioned by the Science and Technology Office of Jiangsu province, Taizhou City Technology Bureau organized experts to conduct final delivery check of the “China Medical City New Drug Research and Development PCRD Integrated Public Service Platform Construction (No. 2011GH580736)” project, which was undertaken by Taizhou Newsummit Biopharma and recognized as one of the 2011 China Torch Program Environment & Construction key projects. The inspection group listened to the report about the project implementation by Mr. Jing Ni, the Executive Deputy General Manager of Taizhou Newsummit Biopharma, then reviewed the requirements in project contract, inspected the documents of the acceptance, and inspected the scene. After discussion the experts group agreed that the implementation of this project had achieved the desired results, and unanimously concluded that the acceptance test shall be passed.

This PCRD platform project obtained state funding of CNY 100 million. Passing this acceptance test helped Newsummit accumulate experience for the forthcoming evaluation of currently ongoing projects, as well as lay the foundation for similar projects application.

Copyright(C)2016,Shanghai Newsummit Biopharma Co.Ltd All Rights Reserved.  Supported by Information Center